Health
Study: Targeting glycoprotein could improve response to cancer immunotherapy – News-Medical.Net
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for…
It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for only a fraction of patients.
The analysis shone a light on one that popped up repeatedly in patients and mouse models that did not respond to immune checkpoint therapy: stanniocalcin-1, a glycoprotein whose role in both tumors and immunology is largely unknown.
By following the trail from this surprising thread, a University of Michigan Rogel…
-
General22 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience
-
Noosa News22 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News17 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan